Natera, Inc. (NTRA): Depreciation & Amortization
$41.76M
Year ended 2025-12-31
$52.67M
Trailing 12 months to 2026-06-30
+35.7%
3-year compound annual growth
+37.1%
5-year compound annual growth
+22.4%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $41.76M | +34.9% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $30.97M | +28.5% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $24.10M | +44.3% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $16.70M | +48.4% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $11.25M | +30.7% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $8.61M | +11.4% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $7.73M | +3.1% | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | $7.50M | +5.0% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $7.14M | +15.7% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $6.18M | +11.6% | 2019-03-15, From 2016-01-01 |
| 2015-12-31 | $5.54M | +7.5% | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | $5.15M | +103.6% | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | $2.53M | n/a | 2016-03-24, From 2013-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Natera, Inc. (NTRA) | 2025-12-31 | $41.76M | +34.9% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $136.10M | +8.6% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $78.00M | -10.2% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $39.74M | -6.3% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $22.61M | -53.8% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $21.41M | -8.7% |
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $570.00M | +15.6% |
| Labcorp Holdings Inc. (LH) | 2025-12-31 | $681.10M | +5.8% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $15.02M | +5.8% |
Compare NTRA, RDNT, FTRE, GH side by side · Screen every company in Services-Medical Laboratories ↗